Hasil Pencarian (1)
small molecule | CAS: 1029044-16-3
Pexidartinib is a selective tyrosine kinase inhibitor that works by inhibiting the colony-stimulating factor (CSF1)/CSF1 receptor pathway. Pexidartinib was originally developed by Daiichi Sankyo, Inc. and it was approved by the FDA in August 2019 as the first…
Kategori:
AminesAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+34
Target Protein:
Macrophage colony-stimulating factor 1 receptorMast/stem cell growth factor receptor KitReceptor-type tyrosine-protein kinase FLT3
+1
Waktu ParuhThe elimination hal…
Vol. DistribusiThe apparent volume…
KlirensThe apparent cleara…
Genetik
-